New Key Statistics Module, Z-Score and F-Score
NAS:ARQT Key Ratios
| Market Cap $ M | 1,266.42 |
| Enterprise Value $ M | 1,144.04 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 8.08 |
| Price/Sales | 9.05 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 138.00 |
| EPS (TTM) $ | -1.79 |
| Beneish M-Score | -1.1 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -33.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.90 |
| EV-to-EBITDA | -7.01 |
| PEG | -- |
| Shares Outstanding M | 117.04 |
| Net Margin (%) | -140.97 |
| Operating Margin % | -131.16 |
| Pre-tax Margin (%) | -140.72 |
| Quick Ratio | 2.38 |
| Current Ratio | 2.46 |
| ROA % (ttm) | -49.01 |
| ROE % (ttm) | -138.99 |
| ROIC % (ttm) | -321.11 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.09 |
ARQT Number of Guru Trades
ARQT Volume of Guru Trades
Gurus Latest Trades with NAS:ARQT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ARQT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Arcutis Biotherapeutics Inc Insider Transactions
No Available Data
News about NAS:ARQT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers